CH
Recombinant Proteins
Recombinant SARS-CoV-2 RBD Protein, C-His
All
TD-VK565021_1.jpg
TD-VK565021_2.jpg
TD-VK565021_3.jpg
TD-VK565021_4.jpg
TD-VK565021_5.jpg
TD-VK565021_6.jpg
TD-VK565021_7.jpg
TD-VK565021_8.jpg
TD-VK565021_9.jpg
TD-VK565021_10.jpg
TD-VK565021_11.jpg
TD-VK565021_12.jpg
  • Article NumberTD-VK565021
  • Specification
    50ug
  • Price
    ¥询价
Customized service consulting

Recombinant SARS-CoV-2 RBD Protein, C-His


Catalog No. TD-VK565021
Expression system Mammalian Cells
Accession P0DTC2
Protein length Arg319-Phe541
Applications ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Species Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Predicted molecular weight 28.03 kDa
Nature Recombinant
Endotoxin level Please contact with the lab for this information.
Purity >90% as determined by SDS-PAGE.
Form Lyophilized
Storage buffer Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution Reconstitute in sterile water for a stock solution.A copy of datasheet will be provided with the products, please refer to it for details.
Shipping In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternate Names Spike glycoprotein, S glycoprotein, E2, Peplomer protein, Spike protein S1, S, Receptor-Binding Domain, RBD, WT
Note For research use only.

 

TD-VK565021_1.jpg
SDS-PAGE
 
SDS-PAGE for Recombinant SARS-CoV-2 RBD Protein, C-His
TD-VK565021_2.jpg
Bioactivity
 
Detects Adintrevimab in indirect ELISAs.
TD-VK565021_3.jpg
Bioactivity
 
Detects Amubarvimab in indirect ELISAs.
TD-VK565021_4.jpg
Bioactivity
 
Detected by Research Grade Anti-SARS-CoV-2 RBD Antibody (CV30) (Cat No.:TD-VK565013) in indirect ELISA.
 
TD-VK565021_5.jpg
Bioactivity
 
Detected by Research Grade Anti-SARS-CoV-2 RBD antibody (CR3022) (Cat No.:TD-VK565033) in indirect ELISA.
TD-VK565021_6.jpg
Bioactivity
 
Detected by Research Grade Casirivimab (Cat No.: TD-VK565046) in indirect ELISA.
TD-VK565021_7.jpg
Bioactivity
 
Detected by Research Grade Anti-SARS-CoV-2 RBD antibody (VHH-72-Fc) (Cat No.: TD-VK565053) in indirect ELISA.
TD-VK565021_8.jpg
Bioactivity
 
Detected by Research Grade Imdevimab (Cat No.: TD-VK565056) in indirect ELISA.
TD-VK565021_9.jpg
Bioactivity
 
Detected by Research Grade Anti-SARS-CoV-2 RBD antibody (EY6A) (Cat No.: TD-VK565063) in indirect ELISA.
TD-VK565021_10.jpg
Bioactivity
 
Detected by Research Grade Anti-SARS-CoV-2 RBD antibody (H4) (Cat No.: TD-VK565083) in indirect ELISA.
TD-VK565021_11.jpg
Bioactivity
 
Detected by Research Grade Rimteravimab (Cat No.: TD-VK565166) in indirect ELISA.
TD-VK565021_12.jpg
Bioactivity
 
Detected by Anti-SARS-CoV-2 NTD antibody (4A8) (Cat No.: TD-VK755013) in indirect ELISA.